COTI2

Critical Outcome Technologies Inc. · Phase 1 active Small molecule

At a glance

Generic name	COTI2
Also known as	CAS 1039455-84-9; 4-(2-pyridinyl)-2-(6,7-dihydro-8(5H)-quinolinylidene)hydrazide-1-piperazinecarbothioic acid
Sponsor	Critical Outcome Technologies Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

COTI2 CI brief — competitive landscape report
COTI2 updates RSS · CI watch RSS
Critical Outcome Technologies Inc. portfolio CI